Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis

Molecular Aspects of Medicine

Volumn 37, Issue , 2014, Pages 35-56

  Pollheimer, Marion J ^a   Fickert, Peter ^a   Stieger, Bruno ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Animal models; Cholangiopathies; Cholestasis; Liver fibrosis; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN G4; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 2; PEPTIDOGLYCAN POLYSACCHARIDE; PYRUVATE DEHYDROGENASE COMPLEX;

BACTERIAL OVERGROWTH; BILE DUCT; BILE DUCT DISEASE; CHOLESTATIC HEPATITIS; CHRONIC LIVER DISEASE; CRYPTOSPORIDIUM PARVUM; HELICOBACTER HEPATICUS; HISTOPATHOLOGY; HUMAN; IGG4 ASSOCIATED CHOLANGITIS; LIVER CELL; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SECONDARY SCLEROSING CHOLANGITIS; BILIARY CIRRHOSIS; CHOLANGITIS, SCLEROSING; CHOLESTASIS; CHRONIC DISEASE; LIVER; PATHOLOGY;

ANIMALIA;

BILE DUCTS; CHOLANGITIS, SCLEROSING; CHOLESTASIS; CHRONIC DISEASE; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY;

EID: 84901235037     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2013.10.001     Document Type: Review

References (259)

1. R. Abdalian, and E.J. Heathcote Sclerosing cholangitis: a focus on secondary causes Hepatology 44 5 2006 1063 1074
2. D.H. Adams, S.G. Hubscher, J. Shaw, G.D. Johnson, C. Babbs, R. Rothlein, and J.M. Neuberger Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis Hepatology 14 3 1991 426 431
3. Y. Aisaka, Y. Watanabe, M. Kamiyasu, T. Masanaga, K. Tsuji, T. Nakanishi, G. Kajiyama, and M.E. Gershwin Immune-mediated cholangiohepatitis in neonatally thymectomized mice: the role of T cells and analysis of T-cell receptor Vbeta usage J. Autoimmun. 14 3 2000 239 246
4. R. Akitake, T. Watanabe, C. Zaima, N. Uza, H. Ida, S. Tada, N. Nishida, and T. Chiba Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease Gut 59 4 2010 542 545
5. M.A. Aller, J.L. Arias, J. Garcia-Dominguez, J.I. Arias, M. Duran, and J. Arias Experimental obstructive cholestasis: the wound-like inflammatory liver response Fibrogenesis Tissue Repair 1 1 2008 6
6. K. Amano, P.S. Leung, R. Rieger, C. Quan, X. Wang, J. Marik, Y.F. Suen, M.J. Kurth, M.H. Nantz, A.A. Ansari, K.S. Lam, M. Zeniya, E. Matsuura, R.L. Coppel, and M.E. Gershwin Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid J. Immunol. 174 9 2005 5874 5883
7. N. Amft, S.J. Curnow, D. Scheel-Toellner, A. Devadas, J. Oates, J. Crocker, J. Hamburger, J. Ainsworth, J. Mathews, M. Salmon, S.J. Bowman, and C.D. Buckley Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome Arthritis Rheum. 44 11 2001 2633 2641
8. J.H. Aron, and C.L. Bowlus The immunobiology of primary sclerosing cholangitis Semin. Immunopathol. 31 3 2009 383 397
9. G. Aust, D. Sittig, L. Becherer, U. Anderegg, A. Schutz, P. Lamesch, and E. Schmucking The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases Eur. J. Endocrinol. 150 2 2004 225 234
10. P. Avenaud, B. Le Bail, K. Mayo, A. Marais, R. Fawaz, P. Bioulac-Sage, and F. Megraud Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement Infect. Immun. 71 6 2003 3667 3672
11. J.M. Banales, J. Prieto, and J.F. Medina Cholangiocyte anion exchange and biliary bicarbonate excretion World J. Gastroenterol. 12 22 2006 3496 3511
12. J.M. Banales, E. Saez, M. Uriz, S. Sarvide, A.D. Urribarri, P. Splinter, P.S. Tietz Bogert, L. Bujanda, J. Prieto, J.F. Medina, and N.F. LaRusso Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis Hepatology 56 2 2012 687 697
13. M. Beaussier, D. Wendum, L. Fouassier, C. Rey, V. Barbu, E. Lasnier, A. Lienhart, J.Y. Scoazec, O. Rosmorduc, and C. Housset Adaptative bile duct proliferative response in experimental bile duct ischemia J. Hepatol. 42 2 2005 257 265
14. J. Benninger, R. Grobholz, Y. Oeztuerk, C.H. Antoni, E.G. Hahn, M.V. Singer, and R. Strauss Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms World J. Gastroenterol. 11 27 2005 4199 4205
15. F. Berr, F.R. Simon, and J. Reichen Ethynylestradiol impairs bile salt uptake and Na-K pump function of rat hepatocytes Am. J. Physiol. 247 4 Pt. 1 1984 G437 G443
16. U. Beuers, S. Hohenester, L.J. de Buy Wenniger, A.E. Kremer, P.L. Jansen, and R.P. Elferink The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies Hepatology 52 4 2010 1489 1496
17. S. Bloom, K. Fleming, and R. Chapman Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis Gut 36 4 1995 604 609
18. X. Bo, U. Broome, M. Remberger, and S. Sumitran-Holgersson Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis Gut 49 1 2001 131 141
19. U.A. Boelsterli, G. Rakhit, and T. Balazs Modulation by S-adenosyl-l-methionine of hepatic Na+, K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis Hepatology 3 1 1983 12 17
20. P.T. Bogert, and N.F. LaRusso Cholangiocyte biology Curr. Opin. Gastroenterol. 23 3 2007 299 305
21. S. Bonin, L. Pascolo, L.S. Croce, G. Stanta, and C. Tiribelli Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases Mol. Med. 8 6 2002 318 325
22. A.T. Borchers, S. Shimoda, C. Bowlus, C.L. Keen, and M.E. Gershwin Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis Semin. Immunopathol. 31 3 2009 309 322
23. P. Borst, N. Zelcer, and A. van Helvoort ABC transporters in lipid transport Biochim. Biophys. Acta 1486 1 2000 128 144
24. R. Bossard, B. Stieger, B. O'Neill, G. Fricker, and P.J. Meier Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver J. Clin. Invest. 91 6 1993 2714 2720
25. J.L. Boyer, J. Graf, and P.J. Meier Hepatic transport systems regulating pHi, cell volume, and bile secretion Annu. Rev. Physiol. 54 1992 415 438
26. O. Briz, M.A. Serrano, R.I. MacIas, J. Gonzalez-Gallego, and J.J. Marin Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin Biochem. J. 371 Pt. 3 2003 897 905
27. J.H. Buckner Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases Nat. Rev. Immunol. 10 12 2010 849 859
28. A.D. Burgstahler, and M.H. Nathanson NO modulates the apicolateral cytoskeleton of isolated hepatocytes by a PKC-dependent, cGMP-independent mechanism Am. J. Physiol. 269 5 Pt. 1 1995 G789 G799
29. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, B. Shneider, and G.J. Gores Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2 2010 660 678
30. H.L. Chen, Y.J. Liu, S.H. Wu, Y.H. Ni, M.C. Ho, H.S. Lai, W.M. Hsu, H.Y. Hsu, H.C. Tseng, Y.M. Jeng, and M.H. Chang Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia Pediatr. Res. 63 6 2008 667 673
31. Y.H. Chuang, Z.X. Lian, C.M. Cheng, R.Y. Lan, G.X. Yang, Y. Moritoki, B.L. Chiang, A.A. Ansari, K. Tsuneyama, R.L. Coppel, and M.E. Gershwin Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives J. Autoimmun. 25 2 2005 126 132
32. Y.H. Chuang, Z.X. Lian, G.X. Yang, S.A. Shu, Y. Moritoki, W.M. Ridgway, A.A. Ansari, M. Kronenberg, R.A. Flavell, B. Gao, and M.E. Gershwin Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis Hepatology 47 2 2008 571 580
33. J.M. Crawford Cellular and molecular biology of the inflamed liver Curr. Opin. Gastroenterol. 13 3 1997 175 185
34. F.A. Crocenzi, C.L. Basiglio, L.M. Perez, M.S. Portesio, E.J. Pozzi, and M.G. Roma Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP Biochem. Pharmacol. 69 2005 1113 1120
35. Y. Cui, J. Konig, I. Leier, U. Buchholz, and D. Keppler Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 J. Biol. Chem. 276 13 2001 9626 9630
36. P.A. Dawson, J. Haywood, A.L. Craddock, M. Wilson, M. Tietjen, K. Kluckman, N. Maeda, and J.S. Parks Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice J. Biol. Chem. 278 36 2003 33920 33927
37. P.A. Dawson, T. Lan, and A. Rao Bile acid transporters J. Lipid Res. 50 12 2009 2340 2357
38. V.J. Desmet Histopathology of chronic cholestasis and adult ductopenic syndrome Clin. Liver Dis. 2 2 1998 249 264 viii
39. A. Dhirapong, A. Lleo, G.X. Yang, K. Tsuneyama, R. Dunn, M. Kehry, T.A. Packard, J.C. Cambier, F.T. Liu, K. Lindor, R.L. Coppel, A.A. Ansari, and M.E. Gershwin B cell depletion therapy exacerbates murine primary biliary cirrhosis Hepatology 53 2 2011 527 535
40. P. Dillon, D. Belchis, T. Tracy, R. Cilley, L. Hafer, and T. Krummel Increased expression of intercellular adhesion molecules in biliary atresia Am. J. Pathol. 145 2 1994 263 267
41. F. Dombrowski, B. Stieger, and U. Beuers Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver Lab. Invest. 86 2 2006 166 174
42. J.F. Dufour, T.J. Turner, and I.M. Arias Nitric oxide blocks bile canalicular contraction by inhibiting inositol trisphosphate-dependent calcium mobilization Gastroenterology 108 3 1995 841 849
43. F.L. Dumoulin, C. Reichel, T. Sauerbruch, and U. Spengler Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction J. Hepatol. 26 4 1997 852 856
44. P.R. Durie, G. Kent, M.J. Phillips, and C.A. Ackerley Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model Am. J. Pathol. 164 4 2004 1481 1493
45. B. Eksteen, A.J. Grant, A. Miles, S.M. Curbishley, P.F. Lalor, S.G. Hubscher, M. Briskin, M. Salmon, and D.H. Adams Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J. Exp. Med. 200 11 2004 1511 1517
46. B. Eksteen, A. Miles, S.M. Curbishley, C. Tselepis, A.J. Grant, L.S. Walker, and D.H. Adams Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10 J. Immunol. 177 1 2006 593 603
47. B. Eksteen, J.R. Mora, E.L. Haughton, N.C. Henderson, L. Lee-Turner, E.J. Villablanca, S.M. Curbishley, A.I. Aspinall, U.H. von Andrian, and D.H. Adams Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells Gastroenterology 137 1 2009 320 329
48. M.G. Elferink, P. Olinga, A.L. Draaisma, M.T. Merema, K.N. Faber, M.J. Slooff, D.K. Meijer, and G.M. Groothuis LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process Am. J. Physiol. Gastrointest. Liver Physiol. 287 5 2004 G1008 G1016
49. D. Ellinghaus, T. Folseraas, K. Holm, E. Ellinghaus, E. Melum, T. Balschun, J.K. Laerdahl, A. Shiryaev, D.N. Gotthardt, T.J. Weismüller, C. Schramm, M. Wittig, A. Bergquist, E. Björnsson, H.U. Marschall, M. Vatn, A. Teufel, C. Rust, C. Gieger, H.E. Wichmann, H. Runz, M. Sterneck, C. Rupp, F. Braun, R.K. Weersma, C. Wijmenga, C.Y. Ponsioen, C.G. Mathew, P. Rutgeerts, S. Vermeire, E. Schrumpf, J.R. Hov, M.P. Manns, K.M. Boberg, S. Schreiber, A. Franke, and T.H. Karlsen Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 Hepatology 58 3 2013 1074 1083
50. J.J. Eloranta, and G.A. Kullak-Ublick The role of FXR in disorders of bile acid homeostasis Physiology (Bethesda) 23 2008 286 295
51. S. Engler, C. Elsing, C. Flechtenmacher, L. Theilmann, W. Stremmel, and A. Stiehl Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders Gut 52 5 2003 688 693
52. I. Esposito, D. Born, F. Bergmann, T. Longerich, T. Welsch, N.A. Giese, M.W. Buchler, J. Kleeff, H. Friess, and P. Schirmacher Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis PLoS ONE 3 7 2008 e2539
53. A. Esteller Physiology of bile secretion World J. Gastroenterol. 14 37 2008 5641 5649
54. M.B. Fallon, A. Mennone, and J.M. Anderson Altered expression and localization of the tight junction protein ZO-1 after common bile duct ligation Am. J. Physiol. 264 6 Pt. 1 1993 C1439 C1447
55. P. Fickert, A. Fuchsbichler, H.U. Marschall, M. Wagner, G. Zollner, R. Krause, K. Zatloukal, H. Jaeschke, H. Denk, and M. Trauner Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice Am. J. Pathol. 168 2 2006 410 422
56. P. Fickert, A. Fuchsbichler, M. Wagner, G. Zollner, A. Kaser, H. Tilg, R. Krause, F. Lammert, C. Langner, K. Zatloukal, H.U. Marschall, H. Denk, and M. Trauner Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 127 1 2004 261 274
57. P. Fickert, U. Stoger, A. Fuchsbichler, T. Moustafa, H.U. Marschall, A.H. Weiglein, O. Tsybrovskyy, H. Jaeschke, K. Zatloukal, H. Denk, and M. Trauner A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis Am. J. Pathol. 171 2 2007 525 536
58. P. Fickert, G. Zollner, A. Fuchsbichler, C. Stumptner, A.H. Weiglein, F. Lammert, H.U. Marschall, O. Tsybrovskyy, K. Zatloukal, H. Denk, and M. Trauner Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles Gastroenterology 123 4 2002 1238 1251
59. T. Folseraas, E. Melum, P. Rausch, B.D. Juran, E. Ellinghaus, A. Shiryaev, J.K. Laerdahl, D. Ellinghaus, C. Schramm, T.J. Weismüller, D.N. Gotthardt, J.R. Hov, O.P. Clausen, R.K. Weersma, M. Janse, K.M. Boberg, E. Björnsson, H.U. Marschall, I. Cleynen, P. Rosenstiel, K. Holm, A. Teufel, C. Rust, C. Gieger, H.E. Wichmann, A. Bergquist, E. Ryu, C.Y. Ponsioen, H. Runz, M. Sterneck, S. Vermeire, U. Beuers, C. Wijmenga, E. Schrumpf, M.P. Manns, K.N. Lazaridis, S. Schreiber, J.F. Baines, A. Franke, and T.H. Karlsen Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci J. Hepatol. 57 2 2012 366 375
60. J.F. Gallegos-Orozco, C. E Yurk, N. Wang, J. Rakela, M.R. Charlton, G.R. Cutting, and V. Balan Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis Am. J. Gastroenterol. 100 4 2005 874 878
61. S. Gehring, E.M. Dickson, M.E. San Martin, N. van Rooijen, E.F. Papa, M.W. Harty, T.F. Tracy Jr., and S.H. Gregory Kupffer cells abrogate cholestatic liver injury in mice Gastroenterology 130 3 2006 810 822
62. A. Geier, P. Fickert, and M. Trauner Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis Nat. Clin. Pract. Gastroenterol. Hepatol. 3 10 2006 574 585
63. A. Geier, M. Wagner, C.G. Dietrich, and M. Trauner Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration Biochim. Biophys. Acta 1773 3 2007 283 308
64. C.M. Gelbmann, P. Rummele, M. Wimmer, F. Hofstadter, B. Gohlmann, E. Endlicher, F. Kullmann, J. Langgartner, and J. Scholmerich Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients Am. J. Gastroenterol. 102 6 2007 1221 1229
65. P. Georgiev, W. Jochum, S. Heinrich, J.H. Jang, A. Nocito, F. Dahm, and P.A. Clavien Characterization of time-related changes after experimental bile duct ligation Br. J. Surg. 95 5 2008 646 656
66. M.E. Gershwin, A.A. Ansari, I.R. Mackay, Y. Nakanuma, A. Nishio, M.J. Rowley, and R.L. Coppel Primary biliary cirrhosis: an orchestrated immune response against epithelial cells Immunol. Rev. 174 2000 210 225
67. E. Geuken, D. Visser, F. Kuipers, H. Blokzijl, H.G. Leuvenink, K.P. de Jong, P.M. Peeters, P.L. Jansen, M.J. Slooff, A.S. Gouw, and R.J. Porte Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation J. Hepatol. 41 2004 1017 1025
68. E. Girodon, D. Sternberg, O. Chazouilleres, C. Cazeneuve, D. Huot, Y. Calmus, R. Poupon, M. Goossens, and C. Housset Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis J. Hepatol. 37 2 2002 192 197
69. A.J. Grant, S. Goddard, J. Ahmed-Choudhury, G. Reynolds, D.G. Jackson, M. Briskin, L. Wu, S.G. Hubscher, and D.H. Adams Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease Am. J. Pathol. 160 4 2002 1445 1455
70. A.J. Grant, P.F. Lalor, S.G. Hubscher, M. Briskin, and D.H. Adams MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease) Hepatology 33 5 2001 1065 1072
71. A.J. Grant, P.F. Lalor, M. Salmi, S. Jalkanen, and D.H. Adams Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease Lancet 359 9301 2002 150 157
72. J.S. Gujral, A. Farhood, M.L. Bajt, and H. Jaeschke Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice Hepatology 38 2 2003 355 363
73. B. Hagenbuch, and P. Dawson The sodium bile salt cotransport family SLC10 Pflugers Arch. 447 5 2004 566 570
74. B. Hagenbuch, and C. Gui Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 38 7-8 2008 778 801
75. B. Hagenbuch, and P.J. Meier Sinusoidal (basolateral) bile salt uptake systems of hepatocytes Semin. Liver Dis. 16 2 1996 129 136
76. B. Hagenbuch, and P.J. Meier Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Arch. 447 2004 653 665
77. S. Hanada, M. Harada, H. Koga, T. Kawaguchi, E. Taniguchi, R. Kumashiro, T. Ueno, Y. Ueno, M. Ishii, S. Sakisaka, and M. Sata Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes Liver Int. 23 1 2003 3 11
78. E. Hashimoto, K.D. Lindor, H.A. Homburger, E.R. Dickson, A.J. Czaja, R.H. Wiesner, and J. Ludwig Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis Mayo Clin. Proc. 68 11 1993 1049 1055
79. S.E. Hazard, and S.B. Patel Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols Pflugers Arch. 453 5 2007 745 752
80. L. Henckaerts, M. Jaspers, W. Van Steenbergen, L. Vliegen, J. Fevery, H. Nuytten, T. Roskams, P. Rutgeerts, J.J. Cassiman, S. Vermeire, and H. Cuppens Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis J. Hepatol. 50 1 2009 150 157
81. M. Heydtmann, P.F. Lalor, J.A. Eksteen, S.G. Hubscher, M. Briskin, and D.H. Adams CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver J. Immunol. 174 2 2005 1055 1062
82. K.J. Hillan, K.E. Hagler, R.N. MacSween, A.M. Ryan, M.E. Renz, H.H. Chiu, R.K. Ferrier, G.L. Bird, A.P. Dhillon, L.D. Ferrell, and S. Fong Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease Liver 19 6 1999 509 518
83. E. Hinoshita, K. Taguchi, A. Inokuchi, T. Uchiumi, N. Kinukawa, M. Shimada, M. Tsuneyoshi, K. Sugimachi, and M. Kuwano Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection J. Hepatol. 35 6 2001 765 773
84. G.M. Hirschfield, E.J. Heathcote, and M.E. Gershwin Pathogenesis of cholestatic liver disease and therapeutic approaches Gastroenterology 139 5 2010 1481 1496
85. G.M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, Y. Lu, X. Gu, E.J. Walker, K. Jing, B.D. Juran, A.L. Mason, R.P. Myers, K.M. Peltekian, C.N. Ghent, C. Coltescu, E.J. Atkinson, E.J. Heathcote, K.N. Lazaridis, C.I. Amos, and K.A. Siminovitch Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants N. Engl. J. Med. 360 24 2009 2544 2555
86. A.F. Hofmann The enterohepatic circulation of bile acids in mammals: form and functions Front. Biosci. 14 2009 2584 2598
87. A.F. Hofmann, and L.R. Hagey Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics Cell. Mol. Life Sci. 65 16 2008 2461 2483
88. S. Hohenester, R.P. Oude-Elferink, and U. Beuers Primary biliary cirrhosis Semin. Immunopathol. 31 3 2009 283 307
89. S. Hohenester, L.M. Wenniger, C.C. Paulusma, S.J. van Vliet, D.M. Jefferson, R.P. Elferink, and U. Beuers A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes Hepatology 55 1 2012 173 183
90. C.D. Howell, J. Li, and W. Chen Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model Hepatology 29 3 1999 766 776
91. W. Hsu, W. Zhang, K. Tsuneyama, Y. Moritoki, W.M. Ridgway, A.A. Ansari, R.L. Coppel, Z.X. Lian, I. Mackay, and M.E. Gershwin Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice Hepatology 49 1 2009 133 140
92. J. Irie, Y. Wu, L.S. Wicker, D. Rainbow, M.A. Nalesnik, R. Hirsch, L.B. Peterson, P.S. Leung, C. Cheng, I.R. Mackay, M.E. Gershwin, and W.M. Ridgway NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis J. Exp. Med. 203 5 2006 1209 1219
93. K. Isse, K. Harada, Y. Zen, T. Kamihira, S. Shimoda, M. Harada, and Y. Nakanuma Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts Hepatology 41 3 2005 506 516
94. C. Jaeger, G. Mayer, R. Henrich, L. Gossner, T. Rabenstein, A. May, E. Guenter, and C. Ell Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up Endoscopy 38 7 2006 730 734
95. M.M. Kaplan, and M.E. Gershwin Primary biliary cirrhosis N. Engl. J. Med. 353 12 2005 1261 1273
96. T.H. Karlsen, and J.R. Hov Genetics of cholestatic liver disease in 2010 Curr. Opin. Gastroenterol. 26 3 2010 251 258
97. S. Kasashima, Y. Zen, A. Kawashima, K. Konishi, H. Sasaki, M. Endo, Y. Matsumoto, K. Kawakami, F. Kasashima, M. Moriya, K. Kimura, H. Ohtake, and Y. Nakanuma Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis Am. J. Surg. Pathol. 32 2 2008 197 204
98. V. Keitel, M. Burdelski, U. Warskulat, T. Kuhlkamp, D. Keppler, D. Haussinger, and R. Kubitz Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis Hepatology 41 2005 1160 1172
99. J.M. Kel, M.J. Girard-Madoux, B. Reizis, and B.E. Clausen TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis J. Immunol. 185 6 2010 3248 3255
100. H. Kikutani, and S. Makino The murine autoimmune diabetes model: NOD and related strains Adv. Immunol. 51 1992 285 322
101. H. Kita, Z.X. Lian, J. Van de Water, X.S. He, S. Matsumura, M. Kaplan, V. Luketic, R.L. Coppel, A.A. Ansari, and M.E. Gershwin Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells J. Exp. Med. 195 1 2002 113 123
102. H. Kita, S. Matsumura, X.S. He, A.A. Ansari, Z.X. Lian, J. Van de Water, R.L. Coppel, M.M. Kaplan, and M.E. Gershwin Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis J. Clin. Invest. 109 9 2002 1231 1240
103. T. Kobayashi, S. Okamoto, Y. Iwakami, A. Nakazawa, T. Hisamatsu, H. Chinen, N. Kamada, T. Imai, H. Goto, and T. Hibi Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes Inflamm. Bowel Dis. 13 7 2007 837 846
104. H. Kojima, A.T. Nies, J. Konig, W. Hagmann, H. Spring, M. Uemura, H. Fukui, and D. Keppler Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis J. Hepatol. 39 5 2003 693 702
105. J. Konig Uptake transporters of the human OATP family. Molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms Handb. Exp. Pharmacol. 201 2011 1 28
106. J. Konig, Y. Cui, A.T. Nies, and D. Keppler A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G156 G164
107. M. Koyabu, K. Uchida, H. Miyoshi, Y. Sakaguchi, T. Fukui, H. Ikeda, M. Takaoka, J. Hirohara, A. Nishio, Y. Uemura, S. Uemoto, and K. Okazaki Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases J. Gastroenterol. 45 7 2010 732 741
108. S.M. Krams, K. Dorshkind, and M.E. Gershwin Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice J. Exp. Med. 170 6 1989 1919 1930
109. S.M. Krams, C.D. Surh, R.L. Coppel, A. Ansari, B. Ruebner, and M.E. Gershwin Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis Hepatology 9 3 1989 411 416
110. S.M. Krams, J. Van de Water, R.L. Coppel, C. Esquivel, J. Roberts, A. Ansari, and M.E. Gershwin Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis Hepatology 12 2 1990 306 313
111. V. Krejci, L.B. Hiltebrand, and G.H. Sigurdsson Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis Crit. Care Med. 34 5 2006 1456 1463
112. E. Kudo-Tanaka, S. Nakatsuka, T. Hirano, M. Kawai, Y. Katada, M. Matsushita, S. Ohshima, M. Ishii, K. Miyatake, T. Tanaka, and Y. Saeki A case of Mikulicz's disease with Th2-biased cytokine profile: possible feature discriminable from Sjogren's syndrome Mod. Rheumatol. 19 6 2009 691 695
113. H. Kulaksiz, D. Heuberger, S. Engler, and A. Stiehl Poor outcome in progressive sclerosing cholangitis after septic shock Endoscopy 40 3 2008 214 218
114. G.A. Kullak-Ublick, G.B. Baretton, M. Oswald, E.L. Renner, G. Paumgartner, and U. Beuers Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis Hepatol. Res. 23 1 2002 78 82
115. T. Lamireau, M. Zoltowska, E. Levy, I. Yousef, J. Rosenbaum, B. Tuchweber, and A. Desmouliere Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion Life Sci. 72 12 2003 1401 1411
116. R.Y. Lan, C. Cheng, Z.X. Lian, K. Tsuneyama, G.X. Yang, Y. Moritoki, Y.H. Chuang, T. Nakamura, S. Saito, S. Shimoda, A. Tanaka, C.L. Bowlus, Y. Takano, A.A. Ansari, R.L. Coppel, and M.E. Gershwin Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis Hepatology 43 4 2006 729 737
117. L. Landmann, S. Angermuller, C. Rahner, and B. Stieger Expression, distribution, and activity of Na+, K+-ATPase in normal and cholestatic rat liver J. Histochem. Cytochem. 46 3 1998 405 410
118. K.N. Lazaridis, M. Strazzabosco, and N.F. Larusso The cholangiopathies: disorders of biliary epithelia Gastroenterology 127 5 2004 1565 1577
119. M. Le Vee, P. Gripon, B. Stieger, and O. Fardel Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta Drug Metab. Dispos. 36 2 2008 217 222
120. M. Le Vee, V. Lecureur, A. Moreau, B. Stieger, and O. Fardel Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes Drug Metab. Dispos. 37 11 2009 2228 2235
121. J.H. Lefkowitch Primary sclerosing cholangitis Arch. Intern. Med. 142 6 1982 1157 1160
122. M.K. Li, and J.M. Crawford The pathology of cholestasis Semin. Liver Dis. 24 1 2004 21 42
123. L. Libbrecht, L. Meerman, F. Kuipers, T. Roskams, V. Desmet, and P. Jansen Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria J. Pathol. 199 2 2003 191 200
124. S.N. Lichtman, and R.B. Sartor Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats Immunol. Res. 10 3-4 1991 528 531
125. E.V. Loftus Jr., G.C. Harewood, C.G. Loftus, W.J. Tremaine, W.S. Harmsen, A.R. Zinsmeister, D.A. Jewell, and W.J. Sandborn PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 1 2005 91 96
126. J. Ludwig, E.R. Dickson, and G.S. McDonald Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch. A Pathol. Anat. Histol. 379 2 1978 103 112
127. S. Lyoumi, M. Abitbol, D. Rainteau, Z. Karim, F. Bernex, V. Oustric, S. Millot, P. Letteron, N. Heming, L. Guillmot, X. Montagutelli, G. Berdeaux, L. Gouya, R. Poupon, J.C. Deybach, C. Beaumont, and H. Puy Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model Gastroenterology 141 4 2011 1509 1519 1519 e1501-1503
128. L. Maillette de Buy Wenniger, E.A. Rauws, and U. Beuers What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree Endoscopy 44 1 2012 66 73
129. I.P. Maly, and L. Landmann Bile duct ligation in the rat causes upregulation of ZO-2 and decreased colocalization of claudins with ZO-1 and occludin Histochem. Cell Biol. 129 3 2008 289 299
130. T. Masanaga, Y. Watanabe, J. Van de Water, P.S. Leung, T. Nakanishi, G. Kajiyama, B.H. Ruebner, R.L. Coppel, and M.E. Gershwin Induction and persistence of immune-mediated cholangiohepatitis in neonatally thymectomized mice Clin. Immunol. Immunopathol. 89 2 1998 141 149
131. A.I. Masyuk, and N.F. LaRusso Aquaporins in the hepatobiliary system Hepatology 43 2 Suppl. 1 2006 S75 S81
132. J.R. Mead, M.J. Arrowood, R.W. Sidwell, and M.C. Healey Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice J. Infect. Dis. 163 6 1991 1297 1304
133. J.F. Medina, A. Martinez, J.J. Vazquez, and J. Prieto Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis Hepatology 25 1 1997 12 17
134. L. Meerman, N.R. Koopen, V. Bloks, H. Van Goor, R. Havinga, B.G. Wolthers, W. Kramer, S. Stengelin, M. Muller, F. Kuipers, and P.L. Jansen Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria Gastroenterology 117 3 1999 696 705
135. P.J. Meier, U. Eckhardt, A. Schroeder, B. Hagenbuch, and B. Stieger Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver Hepatology 26 6 1997 1667 1677
136. P.J. Meier, and B. Stieger Bile salt transporters Annu. Rev. Physiol. 64 2002 635 661
137. G.F. Mells, J.A. Floyd, K.I. Morley, H.J. Cordell, C.S. Franklin, S.Y. Shin, M.A. Heneghan, J.M. Neuberger, P.T. Donaldson, D.B. Day, S.J. Ducker, A.W. Muriithi, E.F. Wheater, C.J. Hammond, M.F. Dawwas, UK PBC Consortium, D.E. Jones, L. Peltonen, G.J. Alexander, R.N. Sandford, and C.A. Anderson Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis Nat. Genet. 43 4 2011 329 332
138. H.E. Meyer zu Schwabedissen, and H.K. Kroemer In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2) Handb. Exp. Pharmacol. 201 2011 325 371
139. M. Miccio, N. Orzes, G.C. Lunazzi, B. Gazzin, R. Corsi, and C. Tiribelli Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity Biochem. Pharmacol. 38 20 1989 3559 3563
140. A. Miles, E. Liaskou, B. Eksteen, P.F. Lalor, and D.H. Adams CCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow Am. J. Physiol. Gastrointest. Liver Physiol. 294 5 2008 G1257 G1267
141. H. Miyoshi, K. Uchida, T. Taniguchi, S. Yazumi, M. Matsushita, M. Takaoka, and K. Okazaki Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis Pancreas 36 2 2008 133 140
142. P. Mombaerts, J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. Papaioannou RAG-1-deficient mice have no mature B and T lymphocytes Cell 68 5 1992 869 877
143. Y. Moritoki, M. Tsuda, K. Tsuneyama, W. Zhang, K. Yoshida, Z.X. Lian, G.X. Yang, W.M. Ridgway, L.S. Wicker, A.A. Ansari, and M.E. Gershwin B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis Cell. Immunol. 268 1 2011 16 23
144. Y. Moritoki, W. Zhang, K. Tsuneyama, K. Yoshida, K. Wakabayashi, G.X. Yang, C. Bowlus, W.M. Ridgway, Y. Ueno, A.A. Ansari, R.L. Coppel, I.R. Mackay, R.A. Flavell, M.E. Gershwin, and Z.X. Lian B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis Gastroenterology 136 3 2009 1037 1047
145. M. Mourelle, A. Salas, J. Vilaseca, F. Guarner, and J.R. Malagelada Induction of chronic cholangitis in the rat by trinitrobenzenesulfonic acid J. Hepatol. 22 2 1995 219 225
146. T. Müller, C. Beutler, A. Hurtado Pico, E. Schott, A. Fischer, A. Pascher, P. Neuhaus, P. Wiedemann, and T. Berg TH2 cytokine-mediated biliary epithelial cell (BEC) barrier disfunction may contribute to immunoglobulin G4 (IGG4) associated sclerosing cholangitis (IAC) J. Hepatol. 54 Suppl. 1 2011 S514
147. Y. Nakagome, Y. Ueno, T. Kogure, K. Fukushima, Y. Moritoki, W.M. Ridgway, M. Eric Gershwin, and T. Shimosegawa Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency J. Autoimmun. 29 1 2007 20 29
148. Y. Nakanuma, T. Karino, and G. Ohta Orcein positive granules in the hepatocytes in chronic intrahepatic cholestasis. Morphological, histochemical and electron X-ray microanalytical examination Virchows Arch. A Pathol. Anat. Histol. 382 1 1979 21 30
149. Y. Nakanuma, and G. Ohta Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis Hepatology 3 3 1983 423 427
150. Y. Nakanuma, K. Tsuneyama, M.E. Gershwin, and M. Yasoshima Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress Semin. Liver Dis. 15 4 1995 313 328
151. H. Nakashima, K. Miyake, M. Moriyama, A. Tanaka, M. Watanabe, Y. Abe, H. Sato, S. Nakamura, and T. Saito An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis Clin. Nephrol. 73 5 2010 385 391
152. A.T. Nies, M. Schwab, and D. Keppler Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs Expert. Opin. Drug. Metab. Toxicol. 4 5 2008 545 568
153. M. Nishimura, H. Umehara, T. Nakayama, O. Yoneda, K. Hieshima, M. Kakizaki, N. Dohmae, O. Yoshie, and T. Imai Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression J. Immunol. 168 12 2002 6173 6180
154. A. Nonomura, N. Kono, H. Minato, and Y. Nakanuma Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft-versus-host disease in mice Pathol. Int. 48 6 1998 421 427
155. Y. Numata, S. Tazuma, T. Nishioka, Y. Ueno, and K. Chayama Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium J. Gastroenterol. Hepatol. 19 8 2004 910 915
156. S. Oertelt, Z.X. Lian, C.M. Cheng, Y.H. Chuang, K.A. Padgett, X.S. He, W.M. Ridgway, A.A. Ansari, R.L. Coppel, M.O. Li, R.A. Flavell, M. Kronenberg, I.R. Mackay, and M.E. Gershwin Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice J. Immunol. 177 3 2006 1655 1660
157. K. Ohba, K. Omagari, K. Murase, H. Hazama, J. Masuda, H. Kinoshita, H. Isomoto, Y. Mizuta, M. Miyazaki, I. Murata, and S. Kohno A possible mouse model for spontaneous cholangitis: serological and histological characteristics of MRL/lpr mice Pathology 34 3 2002 250 256
158. T. Orth, M. Neurath, P. Schirmacher, P.R. Galle, and W.J. Mayet A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-alpha production and autoantibodies J. Hepatol. 33 6 2000 862 872
159. T. Orth, M. Neurath, P. Schirmacher, U. Treichel, K.H. Meyer zum Buschenfelde, and W. Mayet Anti-neutrophil cytoplasmic antibodies in a rat model of trinitrobenzenesulphonic acid-induced liver injury Eur. J. Clin. Invest. 29 11 1999 929 939
160. M. Oswald, G.A. Kullak-Ublick, G. Paumgartner, and U. Beuers Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis Liver 21 4 2001 247 253
161. R.P. Oude Elferink, and C.C. Paulusma Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein) Pflugers Arch. 453 5 2007 601 610
162. R.K. Pachynski, S.W. Wu, M.D. Gunn, and D.J. Erle Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha 4 beta 7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow J. Immunol. 161 2 1998 952 956
163. C. Pauli-Magnus, P.J. Meier, and B. Stieger Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy Semin. Liver Dis. 30 2 2010 147 159
164. S. Perruche, P. Zhang, T. Maruyama, J.A. Bluestone, P. Saas, and W. Chen Lethal effect of CD3-specific antibody in mice deficient in TGF-beta1 by uncontrolled flu-like syndrome J. Immunol. 183 2 2009 953 961
165. M.J. Phillips, T. Azuma, S.L. Meredith, J.A. Squire, C.A. Ackerley, F.G. Pluthero, E.A. Roberts, R.A. Superina, G.A. Levy, and P.A. Marsden Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhood Lancet 362 9390 2003 1112 1119
166. M.J. Pollheimer, E. Halilbasic, P. Fickert, and M. Trauner Pathogenesis of primary sclerosing cholangitis Best Pract. Res. Clin. Gastroenterol. 25 6 2011 727 739
167. M.J. Pollheimer, M. Trauner, and P. Fickert Will we ever model PSC? - "it's hard to be a PSC model!" Clin. Res. Hepatol. Gastroenterol. 35 12 2011 792 804
168. E.M. Ponnuraj, and A.R. Hayward Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum Clin. Exp. Immunol. 128 3 2002 416 420
169. Y. Popov, E. Patsenker, P. Fickert, M. Trauner, and D. Schuppan Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J. Hepatol. 43 6 2005 1045 1054
170. B. Portmann, H. Popper, J. Neuberger, and R. Williams Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients Gastroenterology 88 6 1985 1777 1790
171. B. Portmann, and Y. Zen Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation Histopathology 60 2 2012 236 248
172. B.C. Portmann, and Y. Nakamura Diseases of the bile ducts A.D. Burt, B.C. Portmann, L.D. Ferrell, MacSween's Pathology of the Liver 5th ed. 2007 Churchill Livingstone, Elsevier, Philadelphia 517 581
173. R. Poupon, C. Ping, Y. Chretien, C. Corpechot, O. Chazouilleres, T. Simon, S.C. Heath, F. Matsuda, R.E. Poupon, C. Housset, and V. Barbu Genetic factors of susceptibility and of severity in primary biliary cirrhosis J. Hepatol. 49 6 2008 1038 1045
174. C. Putensen, H. Wrigge, and R. Hering The effects of mechanical ventilation on the gut and abdomen Curr. Opin. Crit. Care 12 2 2006 160 165
175. C. Rahner, B. Stieger, and L. Landmann Structure-function correlation of tight junctional impairment after intrahepatic and extrahepatic cholestasis in rat liver Gastroenterology 110 5 1996 1564 1578
176. J. Reichen, and G. Paumgartner Uptake of bile acids by perfused rat liver Am. J. Physiol. 231 3 1976 734 742
177. J.E. Ros, L. Libbrecht, M. Geuken, P.L. Jansen, and T.A. Roskams High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease J. Pathol. 200 5 2003 553 560
178. M. Roth, A. Obaidat, and B. Hagenbuch OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies Br. J. Pharmacol. 165 2012 1260 1287
179. E. Rubin, F. Schaffner, and H. Popper Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis Am. J. Pathol. 46 1965 387 407
180. P. Ruemmele, F. Hofstaedter, and C.M. Gelbmann Secondary sclerosing cholangitis Nat. Rev. Gastroenterol. Hepatol. 6 5 2009 287 295
181. D.W. Russell Fifty years of advances in bile acid synthesis and metabolism J. Lipid Res. 50 Suppl. 2009 S120 S125
182. T. Saitoh, M. Fujiwara, M. Nomoto, M. Makino, H. Watanabe, K. Ishihara, T. Kamimura, and F. Ichida Hepatic lesions induced by graft-versus-host reaction across MHC class II antigens: an implication for animal model of primary biliary cirrhosis Clin. Immunol. Immunopathol. 49 1 1988 166 172
183. T. Saitoh, Y. Ikarashi, S. Ito, H. Watanabe, M. Fujiwara, and H. Asakura Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity J. Immunol. 145 10 1990 3268 3275
184. S. Sakisaka, T. Kawaguchi, E. Taniguchi, S. Hanada, K. Sasatomi, H. Koga, M. Harada, R. Kimura, M. Sata, N. Sawada, M. Mori, S. Todo, and T. Kurohiji Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis Hepatology 33 6 2001 1460 1468
185. J.T. Salas, J.M. Banales, S. Sarvide, S. Recalde, A. Ferrer, I. Uriarte, R.P. Oude Elferink, J. Prieto, and J.F. Medina Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis Gastroenterology 134 5 2008 1482 1493
186. H. Sarles, J.C. Sarles, R. Muratore, and C. Guien Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am. J. Dig. Dis. 6 1961 688 698
187. M. Sasaki, H. Ikeda, S. Sawada, Y. Sato, and Y. Nakanuma Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis J. Clin. Pathol. 60 10 2007 1102 1107
188. H. Satoh, Y. Zhong, H. Isomura, M. Saitoh, K. Enomoto, N. Sawada, and M. Mori Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells Exp. Cell Res. 222 2 1996 269 274
189. W. Scheppach, G. Druge, G. Wittenberg, J.G. Mueller, A.M. Gassel, H.J. Gassel, and F. Richter Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases Crit. Care Med. 29 2 2001 438 441
190. P. Scheuer Primary biliary cirrhosis Proc. R. Soc. Med. 60 12 1967 1257 1260
191. P. Sheth, N. Delos Santos, A. Seth, N.F. LaRusso, and R.K. Rao Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism Am. J. Physiol. Gastrointest. Liver Physiol. 293 1 2007 G308 G318
192. S. Sheth, J.C. Shea, M.D. Bishop, S. Chopra, M.M. Regan, E. Malmberg, C. Walker, R. Ricci, L.C. Tsui, P.R. Durie, J. Zielenski, and S.D. Freedman Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis Hum. Genet. 113 3 2003 286 292
193. K. Shi, K. Hayashida, M. Kaneko, J. Hashimoto, T. Tomita, P.E. Lipsky, H. Yoshikawa, and T. Ochi Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients J. Immunol. 166 1 2001 650 655
194. S. Shimoda, M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases J. Exp. Med. 181 5 1995 1835 1845
195. B.L. Shneider, V.L. Fox, K.B. Schwarz, C.L. Watson, M. Ananthanarayanan, S. Thevananther, D.M. Christie, W. Hardikar, K.D. Setchell, G. Mieli-Vergani, F.J. Suchy, and A.P. Mowat Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia Hepatology 25 5 1997 1176 1183
196. J. Shoda, M. Kano, K. Oda, J. Kamiya, Y. Nimura, H. Suzuki, Y. Sugiyama, H. Miyazaki, T. Todoroki, S. Stengelin, W. Kramer, Y. Matsuzaki, and N. Tanaka The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function Am. J. Gastroenterol. 96 2001 3368 3378
197. J. Shoda, K. Oda, H. Suzuki, Y. Sugiyama, K. Ito, D.E. Cohen, L. Feng, J. Kamiya, Y. Nimura, H. Miyazaki, M. Kano, Y. Matsuzaki, and N. Tanaka Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi Hepatology 33 5 2001 1194 1205
198. F.R. Simon, J. Fortune, M. Iwahashi, C. Gartung, A. Wolkoff, and E. Sutherland Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters Am. J. Physiol. 271 6 Pt. 1 1996 G1043 G1052
199. P.A. Slott, M.H. Liu, and N. Tavoloni Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat Gastroenterology 99 2 1990 466 477
200. J.J. Smit, A.H. Schinkel, R.P. Oude Elferink, A.K. Groen, E. Wagenaar, L. van Deemter, C.A. Mol, R. Ottenhoff, N.M. van der Lugt, and M.A. van Roon et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Cell 75 3 1993 451 462
201. C. Spirli, L. Fabris, E. Duner, R. Fiorotto, G. Ballardini, T. Roskams, N.F. Larusso, A. Sonzogni, L. Okolicsanyi, and M. Strazzabosco Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes Gastroenterology 124 3 2003 737 753
202. T.E. Starzl, C.W. Putnam, J.F. Hansbrough, K.A. Porter, and H.A. Reid Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair Surgery 81 2 1977 212 221
203. G. Steinhoff, M. Behrend, B. Schrader, A.M. Duijvestijn, and K. Wonigeit Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3 Am. J. Pathol. 142 2 1993 481 488
204. J. Stephens, M. Cosyns, M. Jones, and A. Hayward Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice Hepatology 30 1 1999 27 35
205. B. Stieger Recent insights into the function and regulation of the bile salt export pump (ABCB11) Curr. Opin. Lipidol. 20 2009 176 181
206. B. Stieger The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation Handb. Exp. Pharmacol. 201 2011 205 259
207. B. Stieger, and C.F. Higgins Twenty years of ATP-binding cassette (ABC) transporters Pflugers Arch. 453 5 2007 543
208. B. Stieger, P.J. Meier, and L. Landmann Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells Hepatology 20 1 Pt. 1 1994 201 212
209. M. Strazzabosco, and L. Fabris Functional anatomy of normal bile ducts Anat Rec (Hoboken) 291 6 2008 653 660
210. M. Strazzabosco, C. Spirli, and L. Okolicsanyi Pathophysiology of the intrahepatic biliary epithelium J. Gastroenterol. Hepatol. 15 3 2000 244 253
211. Y. Takakuwa, Y. Kokai, K. Sasaki, H. Chiba, H. Tobioka, M. Mori, and N. Sawada Bile canalicular barrier function and expression of tight-junctional molecules in rat hepatocytes during common bile duct ligation Cell Tissue Res. 307 2 2002 181 189
212. Y. Takeyama, K. Kanegae, S. Inomata, K. Takata, T. Tanaka, S. Ueda, K. Yokoyama, D. Morihara, S. Nishizawa, A. Anan, M. Irie, K. Iwata, S. Shakado, T. Sohda, and S. Sakisaka Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7alpha-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis Med. Mol. Morphol. 43 3 2010 134 138
213. R. Terada, K. Yamamoto, T. Hakoda, N. Shimada, N. Okano, N. Baba, Y. Ninomiya, M.E. Gershwin, and Y. Shiratori Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases Lab. Invest. 83 5 2003 665 672
214. M.E. Thorpe, P.J. Scheuer, and S. Sherlock Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis Gut 8 5 1967 435 448
215. K. Tjandra, T. Le, and M.G. Swain Experimental colitis attenuates development of toxin-induced cholangitis in rats Dig. Dis. Sci. 47 6 2002 1216 1223
216. K. Tjandra, K.A. Sharkey, and M.G. Swain Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis Hepatology 31 2 2000 280 290
217. M. Trauner, and J.L. Boyer Bile salt transporters: molecular characterization, function, and regulation Physiol. Rev. 83 2 2003 633 671
218. M. Trauner, P. Fickert, E. Halilbasic, and T. Moustafa Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases Wien. Med. Wochenschr. 158 19-20 2008 542 548
219. M. Trauner, P. Fickert, and M. Wagner MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes Semin. Liver Dis. 27 1 2007 77 98
220. N. Tsukada, and M.J. Phillips Bile canalicular contraction is coincident with reorganization of pericanalicular filaments and co-localization of actin and myosin-II J. Histochem. Cytochem. 41 3 1993 353 363
221. K. Tsuneyama, Y. Moritoki, K. Kikuchi, and Y. Nakanuma Pathological features of new animal models for primary biliary cirrhosis Int. J. Hepatol. 2012 2012 403954
222. B.Y. Tung, and M.B. Kimmey Biliary complications of orthotopic liver transplantation Dig. Dis. 17 3 1999 133 144
223. B.L. Ungar, J.A. Burris, C.A. Quinn, and F.D. Finkelman New mouse models for chronic Cryptosporidium infection in immunodeficient hosts Infect. Immun. 58 4 1990 961 969
224. E. van de Steeg, E. Wagenaar, C.M. van der Kruijssen, J.E. Burggraaff, D.R. de Waart, R.P. Elferink, K.E. Kenworthy, and A.H. Schinkel Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs J. Clin. Invest. 120 8 2010 2942 2952
225. J. Van de Water, A. Ansari, T. Prindiville, R.L. Coppel, N. Ricalton, B.L. Kotzin, S. Liu, T.E. Roche, S.M. Krams, S. Munoz, and M.E. Gershwin Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis J. Exp. Med. 181 2 1995 723 733
226. J.J. Van den Oord, R. Sciot, and V.J. Desmet Expression of MHC products by normal and abnormal bile duct epithelium J. Hepatol. 3 3 1986 310 317
227. Y.M. Vanwijngaerden, J. Wauters, L. Langouche, S. Vander Perre, C. Liddle, S. Coulter, S. Vanderborght, T. Roskams, A. Wilmer, G. Van den Berghe, and D. Mesotten Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression Hepatology 54 5 2011 1741 1752
228. J.M. Vierling Animal models for primary sclerosing cholangitis Best Pract. Res. Clin. Gastroenterol. 15 4 2001 591 610
229. K. Wakabayashi, Z.X. Lian, Y. Moritoki, R.Y. Lan, K. Tsuneyama, Y.H. Chuang, G.X. Yang, W. Ridgway, Y. Ueno, A.A. Ansari, R.L. Coppel, I.R. Mackay, and M.E. Gershwin IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis Hepatology 44 5 2006 1240 1249
230. K. Wakabayashi, K. Yoshida, P.S. Leung, Y. Moritoki, G.X. Yang, K. Tsuneyama, Z.X. Lian, T. Hibi, A.A. Ansari, L.S. Wicker, W.M. Ridgway, R.L. Coppel, I.R. Mackay, and M.E. Gershwin Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization Clin. Exp. Immunol. 155 3 2009 577 586
231. Y. Wakabayashi, H. Kipp, and I.M. Arias Transporters on demand: intracellular reservoirs and cycling of bile canalicular ABC transporters J. Biol. Chem. 281 38 2006 27669 27673
232. R. Waldram, R. Williams, and R.Y. Calne Bile composition and bile cast formation after transplantation of the liver in man Transplantation 19 5 1975 382 387
233. J.M. Ward, M.R. Anver, D.C. Haines, and R.E. Benveniste Chronic active hepatitis in mice caused by Helicobacter hepaticus Am. J. Pathol. 145 4 1994 959 968
234. N. Watanabe, S. Kojima, S. Takashimizu, Y. Nishizaki, T. Kagawa, and M.J. Phillips Initial site of bile regurgitation following extrahepatic biliary obstruction in living rats J. Gastroenterol. Hepatol. 22 11 2007 1983 1992
235. N. Watanabe, N. Tsukada, C.R. Smith, and M.J. Phillips Motility of bile canaliculi in the living animal: implications for bile flow J. Cell Biol. 113 5 1991 1069 1080
236. S.A. Weinman Electrogenicity of Na(+)-coupled bile acid transporters Yale J. Biol. Med. 70 4 1997 331 340
237. T.J. Weismuller, J. Wedemeyer, S. Kubicka, C.P. Strassburg, and M.P. Manns The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy J. Hepatol. 48 Suppl. 1 2008 S38 S57
238. T.L. Whiteside, S. Lasky, L. Si, and D.H. Van Thiel Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis Hepatology 5 3 1985 468 474
239. S.M. Wiener, R.F. Hoyt Jr., J.R. Deleonardis, R.R. Clevenger, K.R. Jeffries, K. Nagashima, M. Mandel, J. Owens, M. Eckhaus, R.J. Lutz, and B. Safer Manometric changes during retrograde biliary infusion in mice Am. J. Physiol. Gastrointest. Liver Physiol. 279 1 2000 G49 G66
240. C.A. Woolsey, and C.M. Coopersmith Vasoactive drugs and the gut: is there anything new? Curr. Opin. Crit. Care 12 2 2006 155 159
241. N. Wright, A. Hidalgo, J.M. Rodriguez-Frade, S.F. Soriano, M. Mellado, M. Parmo-Cabanas, M.J. Briskin, and J. Teixido The chemokine stromal cell-derived factor-1 alpha modulates alpha 4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addressin cell adhesion molecule-1 and fibronectin J. Immunol. 168 10 2002 5268 5277
242. S.J. Wu, Y.H. Yang, K. Tsuneyama, P.S. Leung, P. Illarionov, M.E. Gershwin, and Y.H. Chuang Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis Hepatology 53 3 2011 915 925
243. T. Wuestefeld, C. Klein, K.L. Streetz, U. Betz, J. Lauber, J. Buer, M.P. Manns, W. Muller, and C. Trautwein Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration J. Biol. Chem. 278 13 2003 11281 11288
244. X. Xia, H. Francis, S. Glaser, G. Alpini, and G. LeSage Bile acid interactions with cholangiocytes World J. Gastroenterol. 12 22 2006 3553 3563
245. S. Yamada, M. Ishii, N. Kisara, R. Nagatomi, and T. Toyota Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver Liver 19 3 1999 253 258
246. S. Yamada, M. Ishii, L.S. Liang, T. Yamamoto, and T. Toyota Small duct cholangitis induced by N-formyl l-methionine l-leucine l-tyrosine in rats J. Gastroenterol. 29 5 1994 631 636
247. G.X. Yang, Z.X. Lian, Y.H. Chuang, Y. Moritoki, R.Y. Lan, K. Wakabayashi, A.A. Ansari, R.A. Flavell, W.M. Ridgway, R.L. Coppel, K. Tsuneyama, I.R. Mackay, and M.E. Gershwin Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice Hepatology 47 6 2008 1974 1982
248. M. Yasoshima, Y. Nakanuma, K. Tsuneyama, J. Van de Water, and M.E. Gershwin Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis J. Pathol. 175 3 1995 319 325
249. K. Yoshida, G.X. Yang, W. Zhang, M. Tsuda, K. Tsuneyama, Y. Moritoki, A.A. Ansari, K. Okazaki, Z.X. Lian, R.L. Coppel, I.R. Mackay, and M.E. Gershwin Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice Hepatology 50 5 2009 1494 1500
250. Y. Zen, K. Harada, M. Sasaki, Y. Sato, K. Tsuneyama, J. Haratake, H. Kurumaya, K. Katayanagi, S. Masuda, H. Niwa, H. Morimoto, A. Miwa, A. Uchiyama, B.C. Portmann, and Y. Nakanuma IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am. J. Surg. Pathol. 28 9 2004 1193 1203
251. Y. Zen, D. Inoue, A. Kitao, M. Onodera, H. Abo, S. Miyayama, T. Gabata, O. Matsui, and Y. Nakanuma IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases Am. J. Surg. Pathol. 33 12 2009 1886 1893
252. Y. Zen, and Y. Nakanuma IgG4-related disease: a cross-sectional study of 114 cases Am. J. Surg. Pathol. 34 12 2010 1812 1819
253. Y. Zen, and Y. Nakanuma IgG4 cholangiopathy Int. J. Hepatol. 2012 2012 472376
254. W. Zhang, R. Sharma, S.T. Ju, X.S. He, Y. Tao, K. Tsuneyama, Z. Tian, Z.X. Lian, S.M. Fu, and M.E. Gershwin Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis Hepatology 49 2 2009 545 552
255. W. Zhang, M. Tsuda, G.X. Yang, K. Tsuneyama, G. Rong, W.M. Ridgway, A.A. Ansari, R.A. Flavell, R.L. Coppel, Z.X. Lian, and M.E. Gershwin Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis Hepatology 52 1 2010 215 222
256. Y. Zhong, K. Enomoto, H. Isomura, N. Sawada, T. Minase, M. Oyamada, Y. Konishi, and M. Mori Localization of the 7H6 antigen at tight junctions correlates with the paracellular barrier function of MDCK cells Exp. Cell Res. 214 2 1994 614 620
257. G. Zollner, P. Fickert, D. Silbert, A. Fuchsbichler, H.U. Marschall, K. Zatloukal, H. Denk, and M. Trauner Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis J. Hepatol. 38 2003 717 727
258. G. Zollner, P. Fickert, R. Zenz, A. Fuchsbichler, C. Stumptner, L. Kenner, P. Ferenci, R.E. Stauber, G.J. Krejs, H. Denk, K. Zatloukal, and M. Trauner Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases Hepatology 33 2001 633 646
259. G. Zollner, M. Wagner, P. Fickert, D. Silbert, J. Gumhold, K. Zatloukal, H. Denk, and M. Trauner Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis Liver Int. 27 7 2007 920 929